Sanofi
SNY
SNY
746 hedge funds and large institutions have $16.3B invested in Sanofi in 2024 Q3 according to their latest regulatory filings, with 92 funds opening new positions, 292 increasing their positions, 231 reducing their positions, and 59 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
746
Holders Change
+28
Holders Change %
+3.9%
% of All Funds
10.79%
Holding in Top 10
13
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+30%
% of All Funds
0.19%
New
92
Increased
292
Reduced
231
Closed
59
Calls
$125M
Puts
$95.4M
Net Calls
+$29.4M
Net Calls Change
-$48.1M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$224M |
| 2 |
Morgan Stanley
New York
|
+$175M |
| 3 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
+$109M |
| 4 |
Jennison Associates
New York
|
+$99.2M |
| 5 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$82.1M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$380M |
| 2 |
GAM
Groupama Asset Management
Paris,
France
|
-$71.9M |
| 3 |
AC
Armistice Capital
New York
|
-$53M |
| 4 |
MF
Magnetar Financial
Evanston,
Illinois
|
-$50.2M |
| 5 |
Dodge & Cox
San Francisco,
California
|
-$46.8M |
